市场调查报告书
商品编码
1557321
医用合成橡胶市场:2024-2029 年预测Medical Elastomers Market - Forecasts from 2024 to 2029 |
全球医用合成橡胶市场预计将从2024年的93.64亿美元增加到2029年的138.25亿美元,复合年增长率为8.10%。
合成橡胶是一种具有高物理性能、柔韧性、热塑性和灭菌性能的材料。这些特性使它们适合医疗应用,例如血压管、流体通道、伤口引流和药物传输系统。
推动市场扩张的主要因素是在一次性医疗用品(例如管子、注射器和阀门)的製造中越来越多地使用合成橡胶。这些医疗设备需要多种物理特性,例如柔韧性以及耐高温和耐化学药品。此外,对人工关节和心臟瓣膜必不可少的植入的需求不断增加,也促进了市场的成长。
此外,硅胶用于生物医学产品的封装,由于产品开发和市场开拓有无数的机会,预计全球需求将大幅成长。
合成橡胶广泛用于製造心血管装置、矫正器具、一般医疗产品、经皮治疗系统、矫正等。如此广泛的使用是由于生物相容性、耐用性、设计灵活性和良好的性能/成本比。这种增长可归因于医疗产品中使用的安全无卤聚合物的需求激增。
多年来,心血管病等重大慢性病的流行已成为重大健康问题。例如,根据世界卫生组织 (WHO) 的统计,心血管疾病是死亡的主要原因之一,估计每年导致 1,790 万人死亡。同样,根据美国心臟学会的一项研究,到2022年,全球因心血管疾病死亡的人数将达到1,980万人。如此高的死亡率强调了用于心血管应用的人造心臟瓣膜和血管移植物的发展,从而增强了对合成橡胶的需求。
合成橡胶的灵活性使其成为创建可用作流体通道或人工瓣膜的可自订管道的理想选择。在医疗保健领域,由于流体输送和药物应用对医用管材的需求不断增加,以及肺癌、气喘和肺纤维化等呼吸系统疾病的迅速增加,对材料的需求正在迅速增加。
此外,人口老化和慢性病数量的增加,对微创医疗程序和一次性管式医疗设备的需求不断增加,也促进了医疗管市场的成长。此外,各种医疗设备公司之间的策略併购预计将推动全球一次性医疗设备的需求和渗透,从而推动市场成长。
全球医用合成橡胶细分市场分析
依类型划分,全球医用合成橡胶市场分为热固性合成橡胶、硅胶、热可塑性橡胶等。由于其高生物相容性、柔韧性以及机械和电阻,硅胶主要用于医疗应用,如医用袋、手套、管材和植入。由于其高偏好,有机硅弹性合成橡胶占据了重要的市场占有率,并将在预测期内稳定成长。类似地,热可塑性橡胶和热固性合成橡胶也被认为表现出持续成长。
依应用划分,全球医用合成橡胶市场分为植入、注射器、医用袋、手套、医用管材等。由于合成橡胶主要用于製造血流管、热缩管、流体通道,并且主要用于快节奏的外科手术,因此医疗管预计将持续成长并占据较大的市场占有率。
持续投资和策略联盟,以加强对微创手术中客製化医疗管的重视,正在推动该领域的整体成长。同样,由于植入将稳定成长。
亚太地区在预测期内将经历指数级增长
按地区划分,全球医用合成橡胶市场分为北美、南美、欧洲、中东和非洲以及亚太地区。由于中国和日本等国家的人口老化以及慢性病的流行以及对医疗干预和治疗的需求不断增加,亚太地区的医用合成橡胶市场显示出巨大的潜力。
此外,不断增加的研发投入、医疗设备的创新以及政府积极改善老年人慢性病治疗的努力,都进一步为区域市场的扩张铺平了道路。
同样,随着创伤、重组和义肢手术规模的扩大,以及合成橡胶成为重组植入的更好替代品并用作组织扩张器,预计北美将出现积极增长。根据美国整形外科医师协会统计,2023年共有157,740例乳房重建手术,比2022年增加了4%。
The global medical elastomer market is expected to reach US$13.825 billion in 2029 from US$9.364 billion in 2024 at 8.10% (CAGR).
Elastomers are materials with high physical performance, flexibility, thermoplastics, and sterilization properties. These properties make them suitable for medical applications such as blood pressure tubing, fluid pathways, wound drainage, and drug delivery systems.
The prime factor propelling the market expansion is the growing use of elastomers in the manufacturing of disposable medical supplies like tubing, syringes, and valves, among other medical devices. These devices require diverse physical features like flexibility and resistance to high temperatures and chemicals. Furthermore, the increasing need for vital implants for prosthetic joints and heart valves has also contributed to market growth.
In addition, silicone is anticipated to experience a notable surge in demand globally as it is used to encapsulate biomedical products and presents countless opportunities for product development and market introduction.
Elastomers are extensively used in the manufacturing of cardiovascular devices, prosthetic devices, general medical care products, transdermal therapeutic systems, orthodontics, etc. This extensive use is due to their biocompatibility, durability, design flexibility, and favorable performance/cost ratios. The growth may be attributed to the surge in demand for safe and halogen-free polymers used in medical products.
Over the years, the prevalence rate of major chronic diseases such as cardiovascular has become a major health issue. For instance, according to the World Health Organization, cardiovascular disease has become one of the leading causes of death, accounting for an estimated 17.9 million annually. Likewise, as per the study conducted by the American College of Cardiology, in 2022, the global number of deaths due to cardiovascular disease reached 19.8 million. Such a high death count will emphasize the development of artificial heart valves and vascular prostheses for cardiovascular applications, thereby bolstering the demand for elastomers.
Elastomers, due to their higher flexibility, have become an ideal choice for making customizable tubes that can be used as fluid pathways and artificial valves. The demand for materials is booming in the healthcare sector owing to the increasing requirement for fluid delivery medical tubes and medication applications and the escalation of respiratory diseases, including lung cancer, asthma, and pulmonary fibrosis.
Moreover, the aging population and rising rates of chronic diseases, followed by the growing need for minimally invasive medical procedures and disposable tube-based medical equipment, all contribute to the medical tube market growth. Additionally, strategic mergers and acquisitions among different medical device companies are anticipated to propel the demand and reach of disposable medical devices globally, thereby propelling market growth.
Global Medical Elastomer Market Segment Analysis
Based on type, the global medical elastomer market is divided into thermoset elastomer, silicone, thermoplastic elastomer, and others. Silicon offers high bio-compatibility processing flexibility and mechanical & electrical resistance, owing to which it is majorly used in medical applications such as medical bags, gloves, tubes, and implants. Due to their high preference, silicon-based elastomers account for a considerable market share and will grow steadily during the forecast period. Likewise, the thermoplastic and thermoset elastomers are estimated to show constant growth.
Application-wise, the global medical elastomer market is analyzed into implants, syringes, medical bags, gloves, medical tubes, and others. Medical tubes are poised for constant growth and will hold a significant market share as the elastomers are mainly used for making blood flow tubing, heat shrink tubing, and fluid pathways, which are majorly used in fast-paced surgical procedures.
The growing emphasis on customized medical tubes in minimally invasive surgeries, followed by ongoing investments and strategic collaboration to bolster them, has bolstered the overall segment growth. Likewise, implants are also expected to grow at a steady rate, fuelled by their growing applicability in artificial heart valves.
Asia Pacific is witnessing exponential growth during the forecast period
Region-wise, the global medical elastomers market is divided into North America, South America, Europe, the Middle East and Africa, and Asia Pacific. The APAC region shows great potential for the medical elastomer market fuelled by the booming chronic disease prevalence which has increased the demand for medical interventions and treatments driven by the large aging populations in countries like China and Japan.
Moreover, the growing research and development investments, technological innovations in medical devices, and favorable government efforts to improve chronic disease treatment for the geriatric population have further paved the way for regional market expansion.
Likewise, North America is also poised for positive growth owing to the growing scale of traumatic, reconstruction, and prosthetic surgeries, where the elastomers form a better alternative for deploying reconstructive implants and also act as tissue expanders. According to the American Society of Plastic Surgeons, in 2023, breast reconstruction surgery witnessed a 4% growth over 2022, with the total number of procedures recorded at 157,740.
The same source also specified that pelvic floor reconstruction procedures experienced a 7% growth in the same year. Additionally, the well-established presence of major market players, namely DuPont, which is investing in establishing new medical elastomer manufacturing units in the country, is augmenting the market expansion. The European and South American regions are expected to grow at a positive rate, whereas the Middle East and Africa will account for a minimal market share during the forecast period.